世界の後天性血友病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acquired Hemophilia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3751
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、後天性血友病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（伝統療法、高度療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・後天性血友病治療の市場動向
・企業の競争状況、市場シェア
・後天性血友病治療の種類別市場規模と予測2016-2027（伝統療法、高度療法）
・後天性血友病治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・後天性血友病治療の北米市場規模2016-2027（アメリカ、カナダ）
・後天性血友病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・後天性血友病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・後天性血友病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・後天性血友病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Baxalta, Inc.、Baxter Healthcare Corporation、Bristol-Myers Squibb、Genentech, Inc.、Novo Nordisk A/S、Ferring B.V.、Sanofi SA）
・結論

Acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages.

Market Analysis and Insights: Global Acquired Hemophilia Treatment Market
The global Acquired Hemophilia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acquired Hemophilia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acquired Hemophilia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acquired Hemophilia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acquired Hemophilia Treatment market.

Global Acquired Hemophilia Treatment Scope and Market Size
Acquired Hemophilia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acquired Hemophilia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Traditional Therapy
Advanced Therapy

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Baxalta, Inc.
Baxter Healthcare Corporation
Bristol-Myers Squibb
Genentech, Inc.
Novo Nordisk A/S
Ferring B.V.
Sanofi SA

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acquired Hemophilia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Traditional Therapy
1.2.3 Advanced Therapy
1.3 Market by Application
1.3.1 Global Acquired Hemophilia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acquired Hemophilia Treatment Market Perspective (2016-2027)
2.2 Acquired Hemophilia Treatment Growth Trends by Regions
2.2.1 Acquired Hemophilia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acquired Hemophilia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Acquired Hemophilia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Acquired Hemophilia Treatment Industry Dynamic
2.3.1 Acquired Hemophilia Treatment Market Trends
2.3.2 Acquired Hemophilia Treatment Market Drivers
2.3.3 Acquired Hemophilia Treatment Market Challenges
2.3.4 Acquired Hemophilia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acquired Hemophilia Treatment Players by Revenue
3.1.1 Global Top Acquired Hemophilia Treatment Players by Revenue (2016-2021)
3.1.2 Global Acquired Hemophilia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Acquired Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acquired Hemophilia Treatment Revenue
3.4 Global Acquired Hemophilia Treatment Market Concentration Ratio
3.4.1 Global Acquired Hemophilia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acquired Hemophilia Treatment Revenue in 2020
3.5 Acquired Hemophilia Treatment Key Players Head office and Area Served
3.6 Key Players Acquired Hemophilia Treatment Product Solution and Service
3.7 Date of Enter into Acquired Hemophilia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acquired Hemophilia Treatment Breakdown Data by Type
4.1 Global Acquired Hemophilia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Acquired Hemophilia Treatment Forecasted Market Size by Type (2022-2027)

5 Acquired Hemophilia Treatment Breakdown Data by Application
5.1 Global Acquired Hemophilia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Acquired Hemophilia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acquired Hemophilia Treatment Market Size (2016-2027)
6.2 North America Acquired Hemophilia Treatment Market Size by Type
6.2.1 North America Acquired Hemophilia Treatment Market Size by Type (2016-2021)
6.2.2 North America Acquired Hemophilia Treatment Market Size by Type (2022-2027)
6.2.3 North America Acquired Hemophilia Treatment Market Size by Type (2016-2027)
6.3 North America Acquired Hemophilia Treatment Market Size by Application
6.3.1 North America Acquired Hemophilia Treatment Market Size by Application (2016-2021)
6.3.2 North America Acquired Hemophilia Treatment Market Size by Application (2022-2027)
6.3.3 North America Acquired Hemophilia Treatment Market Size by Application (2016-2027)
6.4 North America Acquired Hemophilia Treatment Market Size by Country
6.4.1 North America Acquired Hemophilia Treatment Market Size by Country (2016-2021)
6.4.2 North America Acquired Hemophilia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Acquired Hemophilia Treatment Market Size (2016-2027)
7.2 Europe Acquired Hemophilia Treatment Market Size by Type
7.2.1 Europe Acquired Hemophilia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Acquired Hemophilia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Acquired Hemophilia Treatment Market Size by Type (2016-2027)
7.3 Europe Acquired Hemophilia Treatment Market Size by Application
7.3.1 Europe Acquired Hemophilia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Acquired Hemophilia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Acquired Hemophilia Treatment Market Size by Application (2016-2027)
7.4 Europe Acquired Hemophilia Treatment Market Size by Country
7.4.1 Europe Acquired Hemophilia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Acquired Hemophilia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acquired Hemophilia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Acquired Hemophilia Treatment Market Size by Type
8.2.1 Asia-Pacific Acquired Hemophilia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acquired Hemophilia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acquired Hemophilia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Acquired Hemophilia Treatment Market Size by Application
8.3.1 Asia-Pacific Acquired Hemophilia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acquired Hemophilia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acquired Hemophilia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Acquired Hemophilia Treatment Market Size by Region
8.4.1 Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acquired Hemophilia Treatment Market Size (2016-2027)
9.2 Latin America Acquired Hemophilia Treatment Market Size by Type
9.2.1 Latin America Acquired Hemophilia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Acquired Hemophilia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Acquired Hemophilia Treatment Market Size by Type (2016-2027)
9.3 Latin America Acquired Hemophilia Treatment Market Size by Application
9.3.1 Latin America Acquired Hemophilia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Acquired Hemophilia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Acquired Hemophilia Treatment Market Size by Application (2016-2027)
9.4 Latin America Acquired Hemophilia Treatment Market Size by Country
9.4.1 Latin America Acquired Hemophilia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Acquired Hemophilia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acquired Hemophilia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Acquired Hemophilia Treatment Market Size by Type
10.2.1 Middle East & Africa Acquired Hemophilia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acquired Hemophilia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acquired Hemophilia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Acquired Hemophilia Treatment Market Size by Application
10.3.1 Middle East & Africa Acquired Hemophilia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acquired Hemophilia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acquired Hemophilia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Acquired Hemophilia Treatment Market Size by Country
10.4.1 Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Baxalta, Inc.
11.1.1 Baxalta, Inc. Company Details
11.1.2 Baxalta, Inc. Business Overview
11.1.3 Baxalta, Inc. Acquired Hemophilia Treatment Introduction
11.1.4 Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2016-2021)
11.1.5 Baxalta, Inc. Recent Development
11.2 Baxter Healthcare Corporation
11.2.1 Baxter Healthcare Corporation Company Details
11.2.2 Baxter Healthcare Corporation Business Overview
11.2.3 Baxter Healthcare Corporation Acquired Hemophilia Treatment Introduction
11.2.4 Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2016-2021)
11.2.5 Baxter Healthcare Corporation Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Acquired Hemophilia Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Genentech, Inc.
11.4.1 Genentech, Inc. Company Details
11.4.2 Genentech, Inc. Business Overview
11.4.3 Genentech, Inc. Acquired Hemophilia Treatment Introduction
11.4.4 Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2016-2021)
11.4.5 Genentech, Inc. Recent Development
11.5 Novo Nordisk A/S
11.5.1 Novo Nordisk A/S Company Details
11.5.2 Novo Nordisk A/S Business Overview
11.5.3 Novo Nordisk A/S Acquired Hemophilia Treatment Introduction
11.5.4 Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2016-2021)
11.5.5 Novo Nordisk A/S Recent Development
11.6 Ferring B.V.
11.6.1 Ferring B.V. Company Details
11.6.2 Ferring B.V. Business Overview
11.6.3 Ferring B.V. Acquired Hemophilia Treatment Introduction
11.6.4 Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2016-2021)
11.6.5 Ferring B.V. Recent Development
11.7 Sanofi SA
11.7.1 Sanofi SA Company Details
11.7.2 Sanofi SA Business Overview
11.7.3 Sanofi SA Acquired Hemophilia Treatment Introduction
11.7.4 Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2016-2021)
11.7.5 Sanofi SA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acquired Hemophilia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Traditional Therapy
Table 3. Key Players of Advanced Therapy
Table 4. Global Acquired Hemophilia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Acquired Hemophilia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acquired Hemophilia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Acquired Hemophilia Treatment Market Share by Regions (2016-2021)
Table 8. Global Acquired Hemophilia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Acquired Hemophilia Treatment Market Share by Regions (2022-2027)
Table 10. Acquired Hemophilia Treatment Market Trends
Table 11. Acquired Hemophilia Treatment Market Drivers
Table 12. Acquired Hemophilia Treatment Market Challenges
Table 13. Acquired Hemophilia Treatment Market Restraints
Table 14. Global Acquired Hemophilia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Acquired Hemophilia Treatment Market Share by Players (2016-2021)
Table 16. Global Top Acquired Hemophilia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired Hemophilia Treatment as of 2020)
Table 17. Ranking of Global Top Acquired Hemophilia Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Acquired Hemophilia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acquired Hemophilia Treatment Product Solution and Service
Table 21. Date of Enter into Acquired Hemophilia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acquired Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Acquired Hemophilia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Acquired Hemophilia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Acquired Hemophilia Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Acquired Hemophilia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Acquired Hemophilia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Acquired Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Acquired Hemophilia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Acquired Hemophilia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Acquired Hemophilia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Acquired Hemophilia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Acquired Hemophilia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Acquired Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Acquired Hemophilia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Acquired Hemophilia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Acquired Hemophilia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Acquired Hemophilia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Acquired Hemophilia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Acquired Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Acquired Hemophilia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acquired Hemophilia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acquired Hemophilia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Acquired Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Acquired Hemophilia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Acquired Hemophilia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Acquired Hemophilia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Acquired Hemophilia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Acquired Hemophilia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Acquired Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Acquired Hemophilia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acquired Hemophilia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acquired Hemophilia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Baxalta, Inc. Company Details
Table 62. Baxalta, Inc. Business Overview
Table 63. Baxalta, Inc. Acquired Hemophilia Treatment Product
Table 64. Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2016-2021) & (US$ Million)
Table 65. Baxalta, Inc. Recent Development
Table 66. Baxter Healthcare Corporation Company Details
Table 67. Baxter Healthcare Corporation Business Overview
Table 68. Baxter Healthcare Corporation Acquired Hemophilia Treatment Product
Table 69. Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2016-2021) & (US$ Million)
Table 70. Baxter Healthcare Corporation Recent Development
Table 71. Bristol-Myers Squibb Company Details
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Acquired Hemophilia Treatment Product
Table 74. Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2016-2021) & (US$ Million)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. Genentech, Inc. Company Details
Table 77. Genentech, Inc. Business Overview
Table 78. Genentech, Inc. Acquired Hemophilia Treatment Product
Table 79. Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2016-2021) & (US$ Million)
Table 80. Genentech, Inc. Recent Development
Table 81. Novo Nordisk A/S Company Details
Table 82. Novo Nordisk A/S Business Overview
Table 83. Novo Nordisk A/S Acquired Hemophilia Treatment Product
Table 84. Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2016-2021) & (US$ Million)
Table 85. Novo Nordisk A/S Recent Development
Table 86. Ferring B.V. Company Details
Table 87. Ferring B.V. Business Overview
Table 88. Ferring B.V. Acquired Hemophilia Treatment Product
Table 89. Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2016-2021) & (US$ Million)
Table 90. Ferring B.V. Recent Development
Table 91. Sanofi SA Company Details
Table 92. Sanofi SA Business Overview
Table 93. Sanofi SA Acquired Hemophilia Treatment Product
Table 94. Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2016-2021) & (US$ Million)
Table 95. Sanofi SA Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acquired Hemophilia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Traditional Therapy Features
Figure 3. Advanced Therapy Features
Figure 4. Global Acquired Hemophilia Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Acquired Hemophilia Treatment Report Years Considered
Figure 9. Global Acquired Hemophilia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Acquired Hemophilia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Acquired Hemophilia Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Acquired Hemophilia Treatment Market Share by Regions (2022-2027)
Figure 13. Global Acquired Hemophilia Treatment Market Share by Players in 2020
Figure 14. Global Top Acquired Hemophilia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired Hemophilia Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Acquired Hemophilia Treatment Revenue in 2020
Figure 16. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Acquired Hemophilia Treatment Market Share by Type (2016-2027)
Figure 20. North America Acquired Hemophilia Treatment Market Share by Application (2016-2027)
Figure 21. North America Acquired Hemophilia Treatment Market Share by Country (2016-2027)
Figure 22. United States Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acquired Hemophilia Treatment Market Share by Type (2016-2027)
Figure 26. Europe Acquired Hemophilia Treatment Market Share by Application (2016-2027)
Figure 27. Europe Acquired Hemophilia Treatment Market Share by Country (2016-2027)
Figure 28. Germany Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acquired Hemophilia Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Acquired Hemophilia Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Acquired Hemophilia Treatment Market Share by Region (2016-2027)
Figure 38. China Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acquired Hemophilia Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Acquired Hemophilia Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Acquired Hemophilia Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acquired Hemophilia Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Acquired Hemophilia Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Acquired Hemophilia Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Acquired Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Baxalta, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2016-2021)
Figure 58. Baxter Healthcare Corporation Revenue Growth Rate in Acquired Hemophilia Treatment Business (2016-2021)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Acquired Hemophilia Treatment Business (2016-2021)
Figure 60. Genentech, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2016-2021)
Figure 61. Novo Nordisk A/S Revenue Growth Rate in Acquired Hemophilia Treatment Business (2016-2021)
Figure 62. Ferring B.V. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2016-2021)
Figure 63. Sanofi SA Revenue Growth Rate in Acquired Hemophilia Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Global ICU-acquired Acute Kidney Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4343 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ICU（集中治療室）における急性腎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腎前部、内在性腎、腎後部）、用途別市場規模（公立病院、私立病院）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の後天性嚢胞性腎疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Acquired Cystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3750 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、後天性嚢胞性腎疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、その他）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ...

世界の院内感染薬市場規模・現状・予測（2021年-2027年）

Global Hospital Acquired Infections Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4320 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、院内感染薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗菌剤、抗ウイルス剤、抗真菌剤）、用途別市場規模（尿路感染症、人工呼吸器関連肺炎、手術部位感染症、血流感染症、その他院内感染）、主要地域別市場...

世界の院内感染治療市場規模・現状・予測（2021年-2027年）

Global Hospital Acquired Infections Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-4321 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、院内感染治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗菌剤、抗ウイルス剤、抗真菌剤）、用途別市場規模（尿路感染症、人工呼吸器関連肺炎、手術部位感染症、血流感染症、その他院内感染）、主要地域別市...

世界の院内感染 (HAI) 診断市場規模・現状・予測（2021年-2027年）

Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-4325 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、院内感染 (HAI) 診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分子診断、血液検査、尿検査）、用途別市場規模（尿路感染症、肺炎、手術部位感染症、血流感染症、その他院内感染）、主要地域別市場規...

世界の後天性感染症検査市場規模・現状・予測（2021年-2027年）

Global Acquired Infections Testing Market Size, Status and Forecast 2021-2027
QFJ1-3281 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、後天性感染症検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（疾病検査、薬剤耐性検査）、用途別市場規模（病院、診療所、外来手術センター（ASC）、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の希少性ヘマトロジー治療市場規模・現状・予測（2021年-2027年）

Global Rare Hematology Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5982 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、希少性ヘマトロジー治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血漿由来因子、組換え因子）、用途別市場規模（血友病A、血友病B、フォンウィルブランド病、その他）、主要地域別市場規模（北米、アメリ...

世界のACTH欠乏症治療市場規模・現状・予測（2021年-2027年）

Global ACTH Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3753 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ACTH欠乏症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（先天性、後天性）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の無嗅覚症治療市場規模・現状・予測（2021年-2027年）

Global Anosmia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3814 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、無嗅覚症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（特発性無嗅覚症、後天性無嗅覚症）、用途別市場規模（病院、専門診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のICU（集中治療室）における急性腎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global ICU-acquired Acute Kidney Treatment Market The global ICU-acquired Acute Kidney Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
世界の後天性嚢胞性腎疾患治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acquired Cystic Kidney Disease Treatment Drugs Market The global Acquired Cystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accura…
世界の後天性感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acquired Infections Testing Market The global Acquired Infections Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界の院内感染薬市場規模・現状・予測（2021年-2027年） A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infectio…
世界の院内感染治療市場規模・現状・予測（2021年-2027年） A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infectio…